Concept

Mark Whitacre

Résumé
Mark Edward Whitacre (born May 1, 1957) is an American business executive who came to public attention in 1995 when, as president of the Decatur, Illinois-based BioProducts Division at Archer Daniels Midland (ADM), he became the highest-level corporate executive in U.S. history to become a Federal Bureau of Investigation (FBI) whistleblower. For three years (1992–95), Whitacre acted as a cooperating witness for the FBI, which was investigating ADM for price fixing. In the late 1990s, Whitacre was sentenced to nine years in federal prison for embezzling 9.5millionfromADMatthesametimehewasassistingthefederalpricefixinginvestigation.ADMinvestigatedWhitacresactivitiesand,upondiscoveringsuspiciousactivity,requestedtheFBIinvestigateWhitacreforembezzlement.Asaresultof9.5 million from ADM at the same time he was assisting the federal price-fixing investigation. ADM investigated Whitacre's activities and, upon discovering suspicious activity, requested the FBI investigate Whitacre for embezzlement. As a result of 9.5 million in various frauds, Whitacre lost his whistleblower's immunity, and consequently spent eight and a half years in federal prison. He was released in December 2006. Whitacre is currently the chief science officer and President of Operations at Cypress Systems, a California biotechnology firm. Whitacre holds B.S. and M.S. degrees from Ohio State University, and earned a PhD in Nutritional Biochemistry from Cornell University (1983). Whitacre was a PhD scientist at Ralston Purina after he graduated from Cornell University in early 1983. He then was Vice President at Degussa from 1984 to 1989 prior to joining ADM. In late 1989, Whitacre became the President of the BioProducts Division at ADM. In 1992, he was promoted to Corporate Vice President of ADM, as well as being President of the BioProducts Division. On August 9, 1995, Whitacre was terminated for conducting a $9.5 million fraud after ADM learned that he was an FBI informant for three years. Whitacre wore a wire for the FBI assisting in one of the largest price fixing cases in U.S. history, against ADM. After leaving ADM in August 1995, Whitacre was hired as the CEO of Future Health Technologies (FHT), which soon was renamed Biomar International.
À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.